𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma

✍ Scribed by Khanna, C.; Fan, T. M.; Gorlick, R.; Helman, L. J.; Kleinerman, E. S.; Adamson, P. C.; Houghton, P. J.; Tap, W. D.; Welch, D. R.; Steeg, P. S.; Merlino, G.; Sorensen, P. H. B.; Meltzer, P.; Kirsch, D. G.; Janeway, K. A.; Weigel, B.; Randall, L.; Withrow, S. J.; Paoloni, M.; Kaplan, R.; Teicher, B. A.; Seibel, N. L.; Smith, M.; Uren, A.; Patel, S. R.; Trent, J.; Savage, S. A.; Mirabello, L.; Reinke, D.; Barkaukas, D. A.; Krailo, M.; Bernstein, M.

Book ID
121818011
Publisher
American Association for Cancer Research
Year
2014
Tongue
English
Weight
295 KB
Volume
20
Category
Article
ISSN
1078-0432

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

[Progress in Drug Research] Advances in
[Progress in Drug Research] Advances in Targeted Cancer Therapy Volume 63 || Preclinical development of Alimtaβ„’ (Pemetrexed, LY231514), a multitargeted antifolate
✍ Herrling, Paul L.; Matter, Alex; Schultz, Richard M. πŸ“‚ Article πŸ“… 2005 πŸ› BirkhΓ€user-Verlag 🌐 German βš– 172 KB

This volume is the first book to cover the general topic of targeted cancer therapy. It presents a range of targets such as tumor angiogenesis, cell cycle control and cell signalling, COX-2, apoptosis/cell survival, invasion and metastasis and approaches like kinase inhibitors, antisense, and antibo